Recent Posts
Monday Morning Recap: The Week (1.19.15-1.25.15) in Drug & Device Law & Policy
Another Monday, another Monday Morning Recap, the post where we call out recent drug and device law and policy developments that caught our eye and made us think. We hope you find it helpful (and that you’ll feel free to reach out–kate.greenwood@shu.edu–if there are ways we could improve it). The forecast calls for a blizzard […]
Recommended Reading: New Empirical Analysis of False Claims Act Whistleblower Litigation
By Kate Greenwood Cross-Posted at Bill of Health Late last year, the Columbia Law Review published David Freeman Engstrom’s Private Enforcement’s Pathways: Lessons from Qui Tam Litigation, the fourth in a series of articles Professor Engstrom has written on the growth and evolution of qui tam litigation. (My colleague Associate Dean Kathleen Boozang wrote about […]
Speakers Announced for Upcoming SHU Law Behavioral Health Conference
Here’s the flyer for another great, free conference here at Seton Hall Law. This one will be held February 6th and will focus on insurance coverage of mental health and substance abuse treatment.
Monday Morning Recap: The Week (1.2.15-1.18.15) in Drug & Device Law & Policy
Here’s the Monday Morning Recap, this week on Tuesday due to the holiday, the post where we call out recent drug and device law and policy developments that caught our eye and made us think. We hope you find this week’s Recap of interest! 1. Last week, the Food and Drug Administration released a report […]
A “Money Blind” for Research into Maternal-Fetal Medication Risk?
By Kate Greenwood Cross-Posted at Bill of Health A week ago, the Food and Drug Administration announced the results of a review of the medical literature it conducted in response to “recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used during pregnancy.” The literature, FDA determined, is inconclusive. FDA found […]
Recent Comments